Dillman, R O <br/><br/>
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B.  [electronic resource] 

 -  Blood  Nov 1991 
 - 2520-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Leukemia, Myeloid--drug therapy<br/>Male<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Remission Induction<br/>Thioguanine--administration & dosage<br/>Time Factors<br/>Vincristine--administration & dosage